Skip to main content

Advertisement

SpringerLink
Log in

Macro- and micronutrients in African-Americans with heart failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

An emerging body of evidence suggests secondary hyperparathyroidism (SHPT) may be an important covariant of congestive heart failure (CHF), especially in African-Americans (AA) where hypovitaminosis D is prevalent given that melanin, a natural sunscreen, mandates prolonged exposure of skin to sunlight and where a housebound lifestyle imposed by symptomatic CHF limits outdoor activities and hence sunlight exposure. In addition to the role of hypovitaminosis D in contributing to SHPT is the increased urinary and fecal losses of macronutrients Ca2+ and Mg2+ associated with the aldosteronism of CHF and their heightened urinary losses with furosemide treatment of CHF. Thus, a precarious Ca2+ balance seen with reduced serum 25(OH)D is further compromised when AA develop CHF with circulating RAAS activation and are then treated with a loop diuretic. SHPT accounts for a paradoxical Ca2+ overloading of diverse tissues and the induction of oxidative stress at these sites which spills over to the systemic circulation.

In addition to SHPT, hypozincemia and hyposelenemia have been found in AA with compensated and decompensated heart failure and where an insufficiency of these micronutrients may have its origins in inadequate dietary intake, altered rates of absorption or excretion and/or tissue redistribution, and treatment with an ACE inhibitor or AT1 receptor antagonist. Zn and Se deficiencies, which compromise the activity of several endogenous antioxidant defenses, could prove contributory to the severity of heart failure and its progressive nature. These findings call into question the need for nutriceutical treatment of heart failure and which is complementary to today’s pharmaceuticals, especially in AA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alexander M, Grumbach K, Selby J, Brown AF, Washington E. Hospitalization for congestive heart failure. Explaining racial differences. JAMA 1995;274:1037–42.

    Article  PubMed  CAS  Google Scholar 

  2. Philbin EF, DiSalvo TG. Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. Am J Cardiol 1998;82:76–81.

    Article  PubMed  CAS  Google Scholar 

  3. Dries DL, Exner DV, Gersh BJ, Cooper HA, Carson PE, Domanski MJ. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med 1999;340:609–16.

    Article  PubMed  CAS  Google Scholar 

  4. Ofili EO, Mayberry R, Alema-Mensah E, Saleem S, Hamirani K, Jones C, et al. Gender differences and practice implications of risk factors for frequent hospitalization for heart failure in an urban center serving predominantly African-American patients. Am J Cardiol 1999;83:1350–5.

    Article  PubMed  CAS  Google Scholar 

  5. Vaccarino V, Chen YT, Wang Y, Radford MJ, Krumholz HM. Sex differences in the clinical care and outcomes of congestive heart failure in the elderly. Am Heart J 1999;138 (5 Pt 1):835–42.

    Article  PubMed  CAS  Google Scholar 

  6. Lafata JE, Pladevall M, Divine G, Ayoub M, Philbin EF. Are there race/ethnicity differences in outpatient congestive heart failure management, hospital use, and mortality among an insured population? Med Care 2004;42:680–9.

    Article  PubMed  Google Scholar 

  7. Yancy CW. Heart failure in African Americans. Am J Cardiol 2005;96 Suppl 7B:3i–12i.

    Google Scholar 

  8. Thomas KL, East MA, Velazquez EJ, Tuttle RH, Shaw LK, O’Connor CM, et al. Outcomes by race and etiology of patients with left ventricular systolic dysfunction. Am J Cardiol 2005;96:956–63.

    Article  PubMed  Google Scholar 

  9. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985;76:470–3.

    PubMed  CAS  Google Scholar 

  10. Sawaya BP, Monier-Faugere MC, Ratanapanichkich P, Butros R, Wedlund PJ, Fanti P. Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism. Clin Nephrol 2002;57:51–5.

    PubMed  CAS  Google Scholar 

  11. Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 2000;11:330–4.

    PubMed  CAS  Google Scholar 

  12. Perry HM, 3rd, Miller DK, Morley JE, Horowitz M, Kaiser FE, Perry HM, Jr., et al. A preliminary report of vitamin D and calcium metabolism in older African Americans. J Am Geriatr Soc 1993;41:612–6.

    PubMed  Google Scholar 

  13. Fuleihan GE, Gundberg CM, Gleason R, Brown EM, Stromski ME, Grant FD, et al. Racial differences in parathyroid hormone dynamics. J Clin Endocrinol Metab 1994;79:1642–7.

    Article  PubMed  CAS  Google Scholar 

  14. Harris SS, Soteriades E, Coolidge JA, Mudgal S, Dawson-Hughes B. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab 2000;85:4125–30.

    Article  PubMed  CAS  Google Scholar 

  15. Bikle DD, Ettinger B, Sidney S, Tekawa IS, Tolan K. Differences in calcium metabolism between black and white men and women. Miner Electrolyte Metab 1999;25:178–84.

    Article  PubMed  CAS  Google Scholar 

  16. Khouzam RN, Dishmon DA, Farah V, Flax SD, Carbone LD, Weber KT., Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci 2006;331:30–4.

    Article  PubMed  Google Scholar 

  17. LaGuardia SP, Dockery BK, Bhattacharya SK, Nelson MD, Carbone LD, Weber KT. Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure. Am J Med Sci 2006 (In press).

  18. Holick MF. McCollum Award Lecture, 1994: vitamin D—new horizons for the 21st century. Am J Clin Nutr 1994;60:619–30.

    PubMed  CAS  Google Scholar 

  19. Cosman F, Nieves J, Morgan D, Shen V, Sherwood D, Parisien M, et al. Parathyroid hormone secretory response to EDTA-induced hypocalcemia in black and white premenopausal women. Calcif Tissue Int 1999;65:257–61.

    Article  PubMed  CAS  Google Scholar 

  20. Horl WH. The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. Nephrol Dial Transplant 2004;19 Suppl 5:V2–V8.

    Google Scholar 

  21. Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, et al. Loss of bone minerals and strength in rats with aldosteronism. Am J Physiol Heart Circ Physiol 2004;287:H2023–H6.

    Article  PubMed  CAS  Google Scholar 

  22. Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, et al. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 2005;111:871–8.

    Article  PubMed  CAS  Google Scholar 

  23. Rastegar A, Agus Z, Connor TB, Goldberg M. Renal handling of calcium and phosphate during mineralocorticoid “escape” in man. Kidney Int 1972;2:279–86.

    PubMed  CAS  Google Scholar 

  24. Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB. Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 2000;13:169–77.

    PubMed  CAS  Google Scholar 

  25. Resnick LM, Laragh JH. Calcium metabolism and parathyroid function in primary aldosteronism. Am J Med 1985;78:385–90.

    Article  PubMed  CAS  Google Scholar 

  26. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens 1995;8:884–93.

    Article  PubMed  CAS  Google Scholar 

  27. Mason RP, Kalinowski L, Jacob RF, Jacoby AM, Malinski T. Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans. Circulation 2005;112:3795–801.

    Article  PubMed  CAS  Google Scholar 

  28. Massry SG, Smogorzewski M. Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia. Semin Nephrol 1994;14:219–31.

    PubMed  CAS  Google Scholar 

  29. Vidal A, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT. The calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol 2006;290:H286–H94.

    Article  PubMed  CAS  Google Scholar 

  30. Zive MM, Nicklas TA, Busch EC, Myers L, Berenson GS. Marginal vitamin and mineral intakes of young adults: the Bogalusa Heart Study. J Adolesc Health 1996;19:39–47.

    Article  PubMed  CAS  Google Scholar 

  31. Ranganathan R, Nicklas TA, Yang SJ, Berenson GS. The nutritional impact of dairy product consumption on dietary intakes of adults (1995–1996): the Bogalusa Heart Study. J Am Diet Assoc 2005;105:1391–400.

    Article  PubMed  Google Scholar 

  32. Bell RA, Vitolins MZ, Arcury TA, Quandt SA. Food consumption patterns of rural older African American, Native American, and white adults in North Carolina. J Nutr Elder 2003;23:1–16.

    Article  PubMed  Google Scholar 

  33. Lewis SM, Mayhugh MA, Freni SC, Thorn B, Cardoso S, Buffington C, et al. Assessment of antioxidant nutrient intake of a population of southern US African-American and Caucasian women of various ages when compared to dietary reference intakes. J Nutr Health Aging 2003;7:121–8.

    PubMed  CAS  Google Scholar 

  34. Ervin RB, Kennedy-Stephenson J. Mineral intakes of elderly adult supplement and non-supplement users in the third national health and nutrition examination survey. J Nutr 2002;132:3422–7.

    PubMed  CAS  Google Scholar 

  35. Neggers YH, Bindon JR, Dressler WW. The relationship between zinc and copper status and lipid levels in African-Americans. Biol Trace Elem Res 2001;79:1–13.

    Article  PubMed  CAS  Google Scholar 

  36. Neggers YH, Goldenberg RL, Cliver SP, Copper RL. Determinants of zinc intake in low-income black and white pregnant women. Biol Trace Elem Res 1998;64:221–8.

    PubMed  CAS  Google Scholar 

  37. Vitolins MZ, Quandt SA, Case LD, Bell RA, Arcury TA, McDonald J. Vitamin and mineral supplement use by older rural adults. J Gerontol A Biol Sci Med Sci 2000;55:M613–M7.

    PubMed  CAS  Google Scholar 

  38. Rishi I, Baidouri H, Abbasi JA, Bullard-Dillard R, Kajdacsy-Balla A, Pestaner JP, et al. Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl Immunohistochem Mol Morphol 2003;11:253–60.

    PubMed  CAS  Google Scholar 

  39. Arroyo M, LaGuardia SP, Bhattacharya SK, Nelson MD, Johnson PL, Carbone LD, et al. Micronutrients in African-Americans with decompensated and compensated heart failure. J Lab Clin Med 2006 (In press).

  40. Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 1989;80:299–305.

    PubMed  CAS  Google Scholar 

  41. Villarreal D, Freeman RH, Johnson RA. Neurohormonal modulators and sodium balance in experimental heart failure. Am J Physiol 1993;264:H1187–H93.

    PubMed  CAS  Google Scholar 

  42. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 1990;82:1730–6.

    PubMed  CAS  Google Scholar 

  43. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang C, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heartfailure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724–9.

    PubMed  CAS  Google Scholar 

  44. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001;345:1689–97.

    Article  PubMed  CAS  Google Scholar 

  45. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007–18.

    Article  PubMed  Google Scholar 

  46. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293–302.

  47. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709–17.

    Article  PubMed  CAS  Google Scholar 

  48. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001;89:279–86.

    PubMed  CAS  Google Scholar 

  49. Sam F, Kerstetter DL, Pimental DR, Mulukutla S, Tabaee A, Bristow MR, et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 2005;11:473–80.

    Article  PubMed  CAS  Google Scholar 

  50. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998;31:1352–6.

    Article  PubMed  CAS  Google Scholar 

  51. Miyamoto M, Kishimoto C, Shioji K, Lee JD, Shimizu H, Ueda T, et al. Cutaneous arteriolar thioredoxin expression in patients with heart failure. Circ J 2003;67:116–8.

    Article  PubMed  CAS  Google Scholar 

  52. Tsutsui H, Ide T, Hayashidani S, Suematsu N, Shiomi T, Wen J, et al. Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 2001;104:134–6.

    PubMed  CAS  Google Scholar 

  53. Ahokas RA, Warrington KJ, Gerling IC, Sun Y, Wodi LA, Herring PA, et al. Aldosteronism and peripheral blood mononuclear cell activation. A neuroendocrine-immune interface. Circ Res 2003;93:e124–e35.

    Article  PubMed  CAS  Google Scholar 

  54. Ahokas RA, Sun Y, Bhattacharya SK, Gerling IC, Weber KT. Aldosteronism and a proinflammatory vascular phenotype. Role of Mg2+, Ca2+ and H2O2 in peripheral blood mononuclear cells. Circulation 2005;111:51–7.

    Article  PubMed  CAS  Google Scholar 

  55. Gerling IC, Sun Y, Ahokas RA, Wodi LA, Bhattacharya SK, Warrington KJ, et al. Aldosteronism: an immunostimulatory state precedes the proinflammatory/fibrogenic cardiac phenotype. Am J Physiol Heart Circ Physiol 2003;285:H813–H21.

    PubMed  CAS  Google Scholar 

  56. Aukrust P, Ueland T, Müller F, Andreassen AK, Nordòy I, Aas H, et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1998;97:1136–43.

    PubMed  CAS  Google Scholar 

  57. Damras JK, Gullestad L, Ueland T, Solum NO, Simonsen S, Fròland SS, et al. CXC-chemokines, a new group of cytokines in congestive heart failure—possible role of platelets and monocytes. Cardiovasc Res 2000;45:428–36.

    Article  Google Scholar 

  58. Damras JK, Gullestad L, Aass H, Simonsen S, Fjeld JG, Wikeby L, et al. Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure—modulatory effect of intravenous immunoglobulin. J Am Coll Cardiol 2001;38:187–93.

    Article  Google Scholar 

  59. Yndestad A, Damras JK, Eiken HG, Holm T, Haug T, Simonsen S, et al. Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res 2002;54:175–82.

    Article  PubMed  CAS  Google Scholar 

  60. Yndestad A, Holm AM, Müller F, Simonsen S, Fròland SS, Gullestad L, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 2003;60:141–6.

    Article  PubMed  CAS  Google Scholar 

  61. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. Aldosterone-induced inflammation in the rat heart. Role of oxidative stress. Am J Pathol 2002;161:1773–81.

    PubMed  CAS  Google Scholar 

  62. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526–34.

    PubMed  CAS  Google Scholar 

  63. Anker SD, Clark AL, Teixeira MM, Hellewell PG, Coats AJ. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 1999;83:612–5.

    Article  PubMed  CAS  Google Scholar 

  64. Lee AH, Mull RL, Keenan GF, Callegari PE, Dalinka MK, Eisen HJ, et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994;96:35–41.

    Article  PubMed  CAS  Google Scholar 

  65. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997;103:197–207.

    Article  PubMed  CAS  Google Scholar 

  66. Aquilani R, Opasich C, Verri M, Boschi F, Febo O, Pasini E, et al. Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 2003;42:1218–23.

    Article  PubMed  Google Scholar 

  67. Silver MA. Dietary research in heart failure: beyond the salt shaker. J Am Coll Cardiol 2003;42:1224–5.

    Article  PubMed  Google Scholar 

  68. Molavi B, Mehta JL. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol 2004;19:488–93.

    Article  PubMed  Google Scholar 

  69. Ungvari Z, Gupte SA, Recchia FA, Batkai S, Pacher P. Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 2005;3:221–9.

    Article  PubMed  CAS  Google Scholar 

  70. Wykretowicz A, Furmaniuk J, Smielecki J, Deskur-Smielecka E, Szczepanik A, Banaszak A, et al. The oxygen stress index and levels of circulating interleukin-10 and interleukin-6 in patients with chronic heart failure. Int J Cardiol 2004;94:283–7.

    Article  PubMed  Google Scholar 

  71. Shioji K, Nakamura H, Masutani H, Yodoi J. Redox regulation by thioredoxin in cardiovascular diseases. Antioxid Redox Signal 2003;5:795–802.

    Article  PubMed  CAS  Google Scholar 

  72. Takano H, Zou Y, Hasegawa H, Akazawa H, Nagai T, Komuro I. Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. Antioxid Redox Signal 2003;5:789–94.

    Article  PubMed  CAS  Google Scholar 

  73. Demirbag R, Yilmaz R, Erel O, Gultekin U, Asci D, Elbasan Z. The relationship between potency of oxidative stress and severity of dilated cardiomyopathy. Can J Cardiol 2005;21:851–5.

    PubMed  CAS  Google Scholar 

  74. Itoh M, Oh-Ishi S, Hatao H, Leeuwenburgh C, Selman C, Ohno H, et al. Effects of dietary calcium restriction and acute exercise on the antioxidant enzyme system and oxidative stress in rat diaphragm. Am J Physiol Regul Integr Comp Physiol 2004;287:R33–R8.

    PubMed  CAS  Google Scholar 

  75. Dhalla AK, Singal PK. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol 1994;266 (4 Pt 2):H1280–H5.

    PubMed  CAS  Google Scholar 

  76. Thakur S, Gupta N, Kakkar P. Serum copper and zinc concentrations and their relation to superoxide dismutase in severe malnutrition. Eur J Pediatr 2004;163:742–4.

    Article  PubMed  CAS  Google Scholar 

  77. Xia YM, Hill KE, Burk RF. Biochemical studies of a selenium-deficient population in China: measurement of selenium, glutathione peroxidase and other oxidant defense indices in blood. J Nutr 1989;119:1318–26.

    PubMed  CAS  Google Scholar 

  78. Thomas M, Vidal A, Bhattacharya SK, Ahokas RA, Johnson PL, Sun Y, et al. Hypozincemia and oxidative stress in rats with chronic aldosteronism. [abstr] J Investig Med 2006;54 Suppl 1:S264.

    Google Scholar 

  79. Latman NS, Sorensen JR, Kishore V. Effect of aldosterone on the serum zinc, copper, and magnesium concentrations in the rat. Horm Res 1984;20:192–6.

    PubMed  CAS  Google Scholar 

  80. Malette LE, Henkin RI. Altered copper and zinc metabolism in primary hyperparathyroidism. Am J Med Sci 1976;272:167–74.

    PubMed  CAS  Google Scholar 

  81. Chen SM, Kuo CD, Liao JF, Ho LT. Effects of parathyroid hormone on plasma zinc concentration in rat with chronic renal failure. Chin J Physiol 2005;48:121–8.

    PubMed  CAS  Google Scholar 

  82. Zumkley H, Bertram HP, Vetter H, Zidek W, Losse H. Zinc metabolism during captopril treatment. Horm Metab Res 1985;17:256–8.

    Article  PubMed  CAS  Google Scholar 

  83. Koren-Michowitz M, Dishy V, Zaidenstein R, Yona O, Berman S, Weissgarten J, et al. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study. Am J Hypertens 2005;18:358–63.

    Article  PubMed  CAS  Google Scholar 

  84. Wester PO. Urinary zinc excretion during treatment with different diuretics. Acta Med Scand 1980;208:209–12.

    Article  PubMed  CAS  Google Scholar 

  85. Cohanim M, Yendt ER. The effects of thiazides on serum and urinary zinc in patients with renal calculi. Johns Hopkins Med J 1975;136:137–41.

    PubMed  CAS  Google Scholar 

  86. Abu-Hamdan DK, Desai H, Sondheimer J, Felicetta J, Mahajan S, McDonald F. Taste acuity and zinc metabolism in captopril-treated hypertensive male patients. Am J Hypertens 1988;1 (3 Pt 3):303S–8S.

    PubMed  CAS  Google Scholar 

  87. Kotsaki-Kovatsi VP, Koehler-Samouilidis G, Kovatsis A, Rozos G. Fluctuation of zinc, copper, magnesium and calcium concentrations in guinea pig tissues after administration of captopril (SQ 14225). J Trace Elem Med Biol 1997;11:32–6.

    PubMed  CAS  Google Scholar 

  88. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991;69:107–15.

    PubMed  CAS  Google Scholar 

  89. Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin EL. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 2003;42:49–55.

    Article  PubMed  CAS  Google Scholar 

  90. Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002;40:504–10.

    Article  PubMed  CAS  Google Scholar 

  91. Goodwin KD, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT. Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements. Am J Med Sci 2006 (In press).

  92. Horton R, Biglieri EG. Effect of aldosterone on the metabolism of magnesium. J Clin Endocrinol Metab 1962;22:1187–92.

    Article  PubMed  CAS  Google Scholar 

  93. Gehr MK, Goldberg M. Hypercalciuria of mineralocorticoid escape: clearance and micropuncture studies in the rat. Am J Physiol 1986;251 (5 Pt 2):F879-F88.

    PubMed  CAS  Google Scholar 

  94. Stefenelli T, Pacher R, Woloszczuk W, Glogar D, Kaindl F. Parathyroid hormone and calcium behavior in advanced congestive heart failure [German]. Z Kardiol 1992;81:121–5.

    PubMed  CAS  Google Scholar 

  95. Christ E, Linka A, Junga G, Odermatt M, Steinert H, Kiowski W, et al. Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease [German]. Schweiz Med Wochenschr 1996;126:1553–9.

    PubMed  CAS  Google Scholar 

  96. Schmid C, Kiowski W. Hyperparathyroidism in congestive heart failure. Am J Med 1998;104:508–9.

    PubMed  CAS  Google Scholar 

  97. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003;41:105–12.

    Article  PubMed  CAS  Google Scholar 

  98. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res 2006;21:163–70.

    Article  PubMed  CAS  Google Scholar 

  99. Ooms ME, Lips P, Van Lingen A, Valkenburg HA. Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women. J Bone Miner Res 1993;8:669–75.

    Article  PubMed  CAS  Google Scholar 

  100. Stein MS, Scherer SC, Walton SL, Gilbert RE, Ebeling PR, Flicker L, et al. Risk factors for secondary hyperparathyroidism in a nursing home population. Clin Endocrinol (Oxf) 1996;44:375–83.

    Article  CAS  Google Scholar 

  101. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004;89–90:387–92.

    Article  PubMed  CAS  Google Scholar 

  102. Seligmann H, Halkin H, Rauchfleisch S, Kaufmann N, Motro M, Vered Z, et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med 1991;91:151–5.

    Article  PubMed  CAS  Google Scholar 

  103. Dunn MA, Cousins RJ. Kinetics of zinc metabolism in the rat: effect of dibutyryl cAMP. Am J Physiol 1989;256:E420–E30.

    PubMed  CAS  Google Scholar 

  104. Lowe NM, Bremner I, Jackson MJ. Plasma 65Zn kinetics in the rat. Br J Nutr 1991;65:445–55.

    Article  PubMed  CAS  Google Scholar 

  105. House WA, Wastney ME. Compartmental analysis of zinc kinetics in mature male rats. Am J Physiol 1997;273:R1117-R25.

    PubMed  CAS  Google Scholar 

  106. Pfaffl MW, Windisch W. Influence of zinc deficiency on the mRNA expression of zinc transporters in adult rats. J Trace Elem Med Biol 2003;17:97–106.

    Article  PubMed  CAS  Google Scholar 

  107. Pfaffl MW, Gerstmayer B, Bosio A, Windisch W. Effect of zinc deficiency on the mRNA expression pattern in liver and jejunum of adult rats: monitoring gene expression using cDNA microarrays combined with real-time RT-PCR. J Nutr Biochem 2003;14:691–702.

    Article  PubMed  CAS  Google Scholar 

  108. Cousins RJ, Blanchard RK, Moore JB, Cui L, Green CL, Liuzzi JP, et al. Regulation of zinc metabolism and genomic outcomes. J Nutr 2003;133 (5 Suppl 1):1521S–6S.

    PubMed  CAS  Google Scholar 

  109. King JC. Assessment of zinc status. J Nutr 1990;120 Suppl 11:1474–9.

    PubMed  CAS  Google Scholar 

  110. Bales CW, DiSilvestro RA, Currie KL, Plaisted CS, Joung H, Galanos AN, et al. Marginal zinc deficiency in older adults: responsiveness of zinc status indicators. J Am Coll Nutr 1994;13:455–62.

    PubMed  CAS  Google Scholar 

  111. Borghesi LA, Lynes MA. Stress proteins as agents of immunological change: some lessons from metallothionein. Cell Stress Chaperones 1996;1:99–108.

    Article  PubMed  CAS  Google Scholar 

  112. Ding HQ, Zhou BJ, Liu L, Cheng S. Oxidative stress and metallothionein expression in the liver of rats with severe thermal injury. Burns 2002;28:215–21.

    Article  PubMed  CAS  Google Scholar 

  113. Liu J, Squibb KS, Akkerman M, Nordberg GF, Lipsky M, Fowler BA. Cytotoxicity, zinc protection, and stress protein induction in rat proximal tubule cells exposed to cadmium chloride in primary cell culture. Ren Fail 1996;18:867–82.

    PubMed  CAS  Google Scholar 

  114. Klosterhalfen B, Tons C, Hauptmann S, Tietze L, Offner FA, Kupper W, et al. Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia. Biochem Pharmacol 1996;52:1201–10.

    Article  PubMed  CAS  Google Scholar 

  115. Ebadi M, Leuschen MP, el Refaey H, Hamada FM, Rojas P. The antioxidant properties of zinc and metallothionein. Neurochem Int 1996;29:159–66.

    Article  PubMed  CAS  Google Scholar 

  116. Prabhu KS, Zamamiri-Davis F, Stewart JB, Thompson JT, Sordillo LM, Reddy CC. Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-kappaB in up-regulation. Biochem J 2002;366 (Pt 1):203–9.

    PubMed  CAS  Google Scholar 

  117. Reddi AS, Bollineni JS. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats. Kidney Int 2001;59:1342–53.

    Article  PubMed  CAS  Google Scholar 

  118. Moreno-Reyes R, Egrise D, Neve J, Pasteels JL, Schoutens A. Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia. J Bone Miner Res 2001;16:1556–63.

    Article  PubMed  CAS  Google Scholar 

  119. Venardos K, Harrison G, Headrick J, Perkins A. Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia-reperfusion. J Trace Elem Med Biol 2004;18:81–8.

    Article  PubMed  CAS  Google Scholar 

  120. Wu Q, Huang K, Xu H. Effects of long-term selenium deficiency on glutathione peroxidase and thioredoxin reductase activities and expressions in rat aorta. J Inorg Biochem 2003;94:301–6.

    Article  PubMed  CAS  Google Scholar 

  121. Wu Q, Huang K. Effect of long-term Se deficiency on the antioxidant capacities of rat vascular tissue. Biol Trace Elem Res 2004;98:73–84.

    Article  PubMed  CAS  Google Scholar 

  122. Faure P, Ramon O, Favier A, Halimi S. Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. Eur J Clin Invest 2004;34:475–81.

    Article  PubMed  CAS  Google Scholar 

  123. Quercia RA, Korn S, O’Neill D, Dougherty JE, Ludwig M, Schweizer R, et al. Selenium deficiency and fatal cardiomyopathy in a patient receiving long-term home parenteral nutrition. Clin Pharm 1984;3:531–5.

    PubMed  CAS  Google Scholar 

  124. Hatanaka N, Nakaden H, Yamamoto Y, Matsuo S, Fujikawa T, Matsusue S. Selenium kinetics and changes in glutathione peroxidase activities in patients receiving long-term parenteral nutrition and effects of supplementation with selenite. Nutrition 2000;16:22–6.

    Article  PubMed  CAS  Google Scholar 

  125. Weiss SL, Evenson JK, Thompson KM, Sunde RA. The selenium requirement for glutathione peroxidase mRNA level is half of the selenium requirement for glutathione peroxidase activity in female rats. J Nutr 1996;126:2260–7.

    PubMed  CAS  Google Scholar 

  126. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003;8:223–46.

    PubMed  Google Scholar 

  127. Bao B, Prasad AS, Beck FW, Godmere M. Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 2003;285:E1095–E102.

    PubMed  CAS  Google Scholar 

  128. Santos-Neto L, Tosta CE, Dorea JG. Zinc reverses the increased sensitivity of lymphocytes from aged subjects to the antiproliferative effect of prostaglandin E2. Clin Immunol Immunopathol 1992;64:184–7.

    Article  PubMed  CAS  Google Scholar 

  129. Lesourd BM. Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. Am J Clin Nutr 1997;66:478S–84S.

    PubMed  CAS  Google Scholar 

  130. Klecha AJ, Salgueiro J, Wald M, Boccio J, Zubillaga M, Leonardi NM, et al. In vivo iron and zinc deficiency diminished T- and B-selective mitogen stimulation of murine lymphoid cells through protein kinase C-mediated mechanism. Biol Trace Elem Res 2005;104:173–83.

    Article  PubMed  CAS  Google Scholar 

  131. Ferencik M, Ebringer L. Modulatory effects of selenium and zinc on the immune system. Folia Microbiol (Praha) 2003;48:417–26.

    Article  CAS  Google Scholar 

  132. van Rij AM, Thomson CD, McKenzie JM, Robinson MF. Selenium deficiency in total parenteral nutrition. Am J Clin Nutr 1979;32:2076–85.

    PubMed  CAS  Google Scholar 

  133. Reeves WC, Marcuard SP, Willis SE, Movahed A. Reversible cardiomyopathy due to selenium deficiency. JPEN J Parenter Enteral Nutr 1989;13:663–5.

    PubMed  CAS  Google Scholar 

  134. Sullivan JF, Blotcky AJ, Jetton MM, Hahn HK, Burch RE. Serum levels of selenium, calcium, copper magnesium, manganese and zinc in various human diseases. J Nutr 1979;109:1432–7.

    PubMed  CAS  Google Scholar 

  135. Koch J, Neal EA, Schlott MJ, Garcia-Shelton YL, Chan MF, Weaver KE, et al. Zinc levels and infections in hospitalized patients with AIDS. Nutrition 1996;12:515–8.

    Article  PubMed  CAS  Google Scholar 

  136. van Lettow M, Harries AD, Kumwenda JJ, Zijlstra EE, Clark TD, Taha TE, et al. Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi. BMC Infect Dis 2004;4:61.

    Article  PubMed  Google Scholar 

  137. Dworkin BM, Rosenthal WS, Wormser GP, Weiss L, Nunez M, Joline C, et al. Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and aids-related complex. Biol Trace Elem Res 1988;15:167–77.

    Article  PubMed  CAS  Google Scholar 

  138. Kavanaugh-McHugh AL, Ruff A, Perlman E, Hutton N, Modlin J, Rowe S. Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1991;15:347–9.

    Article  PubMed  CAS  Google Scholar 

  139. Vijaya J, Subramanyam G, Sukhaveni V, Abdul Latheef SA, Gupta SR, Sadhasivaiah G, et al. Selenium levels in dilated cardiomyopathy. J Indian Med Assoc 2000;98:166–9.

    PubMed  CAS  Google Scholar 

  140. Ripa S, Ripa R, Giustiniani S. Are failured cardiomyopathies a zinc-deficit related disease? A study on Zn and Cu in patients with chronic failured dilated and hypertrophic cardiomyopathies. Minerva Med 1998;89:397–403.

    PubMed  CAS  Google Scholar 

  141. Oster O. Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy. Clin Chim Acta 1993;214:209–18.

    Article  PubMed  CAS  Google Scholar 

  142. Golik A, Modai D, Averbukh Z, Sheffy M, Shamis A, Cohen N, et al. Zinc metabolism in patients treated with captopril versus enalapril. Metabolism 1990;39:665–7.

    Article  PubMed  CAS  Google Scholar 

  143. Golik A, Zaidenstein R, Dishi V, Blatt A, Cohen N, Cotter G, et al. Effects of captopril and enalapril on zincmetabolism in hypertensive patients. J Am Coll Nutr 1998;17:75–8.

    PubMed  CAS  Google Scholar 

  144. Rubio-Luengo MA, Maldonado-Martin A, Gil-Extremera B, Gonzalez-Gomez L, Luna del Castillo JD. Variations in magnesium and zinc in hypertensive patients receiving different treatments. Am J Hypertens 1995;8:689–95.

    Article  PubMed  CAS  Google Scholar 

  145. Djordjevic VB, Grubor-Lajsic G, Jovanovic-Galovic A, Pavlovic D, Cvetkovic T, Pejovic M, et al. Selenium-dependent GSH-Px in erythrocytes of patients with hypertension treated with ACE inhibitors. J Environ Pathol Toxicol Oncol 1998;17:277–80.

    PubMed  CAS  Google Scholar 

  146. Chel VG, Ooms ME, Popp-Snijders C, Pavel S, Schothorst AA, Meulemans CC, et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res 1998;13:1238–42.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA

    Syamal K. Bhattacharya

  2. Department of Obstetrics & Gynecology, University of Tennessee Health Science Center, Memphis, Tennessee, USA

    Robert A. Ahokas

  3. Division of Connective Tissue Diseases, University of Tennessee Health Science Center, Memphis, Tennessee, USA

    Laura D. Carbone

  4. Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, Tennessee, USA

    Syamal K. Bhattacharya, Kevin P. Newman, Yao Sun & Karl T. Weber

  5. Division of Endocrinology, University of Tennessee Health Science Center, Memphis, Tennessee, USA

    Ivan C. Gerling

  6. Veterans Affairs Medical Center, Memphis, Tennessee, USA

    Laura D. Carbone & Ivan C. Gerling

Authors
  1. Syamal K. Bhattacharya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert A. Ahokas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura D. Carbone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kevin P. Newman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ivan C. Gerling
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yao Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Karl T. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karl T. Weber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhattacharya, S.K., Ahokas, R.A., Carbone, L.D. et al. Macro- and micronutrients in African-Americans with heart failure. Heart Fail Rev 11, 45–55 (2006). https://doi.org/10.1007/s10741-006-9192-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-006-9192-6

Keywords

Search

Navigation